Serina Therapeutics
SER
51 hedge funds and large institutions have $11.9M invested in Serina Therapeutics in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 11 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.01% less ownership
Funds ownership: 0.5% → 0.49% (-0.01%)
9% less funds holding
Funds holding: 56 → 51 (-5)
9% less capital invested
Capital invested by funds: $13.1M → $11.9M (-$1.22M)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$32.2K |
| 2 |
Morgan Stanley
New York
|
+$29.2K |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$27.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19K |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Defender Capital
Charlotte,
North Carolina
|
-$103K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$96.8K |
| 3 |
PCM
Price Capital Management
Lafayette,
Louisiana
|
-$47K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$39.6K |
| 5 |
Squarepoint
New York
|
-$38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FANJ
51
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$1K | -11 | Closed |
|
|
FCA
52
FinTrust Capital Advisors
Greenville,
South Carolina
| – | +$108 | +2 | New |
|
53
Rockefeller Capital Management
New York
| – | +$162 | +3 | New |
|
|
APWM
54
Atlas Private Wealth Management
Albany,
New York
| – | +$270 | +5 | New |
|
SER Hedge Fund Activity: Q4 2019 in Review
51 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2019, worth a combined $11.9M — down 9.3% from $13.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of SER and 6 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 15 added.
The largest buyer was JP Morgan Chase, adding an estimated $32.2K. The largest seller was Defender Capital, cutting an estimated $103K.
- 51 institutional investors held Serina Therapeutics (SER) as of Q4 2019, down from 56 in Q3 2019.
- Funds reported $11.9M of Serina Therapeutics stock for Q4 2019, down 9.3% quarter-over-quarter.
- 6 funds opened new Serina Therapeutics positions in Q4 2019 and 11 closed out, a net change of -5 holders.
- The largest Serina Therapeutics buyer in Q4 2019 was JP Morgan Chase, an estimated $32.2K added.
- The largest Serina Therapeutics seller in Q4 2019 was Defender Capital, an estimated $103K sold.
Based on aggregated 13F filings for Q4 2019.